Vertex EVP Joy Liu sells 978 shares in plan trade
Vertex Pharmaceuticals executive Joy Liu, EVP and Chief Legal Officer, sold 978 shares of Common Stock in an open-market transaction on April 1, 2026, at an average price of $449.17 per share.
Rhea-AI Filing Summary
Vertex Pharmaceuticals executive Joy Liu, EVP and Chief Legal Officer, sold 978 shares of Common Stock in an open-market transaction on April 1, 2026, at an average price of $449.17 per share. The sale was made under a company-approved Rule 10b5-1 trading plan entered into on November 25, 2025.
Following this planned sale, Liu directly holds 21,833 Vertex shares. The filing characterizes this as a routine insider transaction executed pursuant to a pre-arranged trading plan rather than a discretionary trade based on short-term market views.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 978 shares
Net Sell
1 txn
Insider
Liu Joy
Role
EVP and Chief Legal Officer
Sold
978 shs ($439K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 978 | $449.17 | $439K |
Holdings After Transaction:
Common Stock — 21,833 shares (Direct)
Footnotes (1)
- F1. Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.
Key Figures
Shares sold: 978 shares
Sale price: $449.17 per share
Shares held after transaction: 21,833 shares
+1 more
4 metrics
Shares sold
978 shares
Open-market sale on April 1, 2026
Sale price
$449.17 per share
Average sale price for Common Stock
Shares held after transaction
21,833 shares
Direct ownership following reported sale
Reported net share change
-978 shares
Net-sell direction in transaction summary
Key Terms
Rule 10b5-1, open-market sale, Common Stock, Form 4, +1 more
5 terms
Rule 10b5-1 regulatory
"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
trading plan financial
"company approved trading plan under Rule 10b5-1"
A trading plan is a written set of rules an investor follows about what to buy or sell, when to enter and exit positions, and how much risk to accept—like a travel itinerary that maps the route, stops, and budget before a trip. It matters because it helps remove emotional decisions during market swings, enforces discipline, and makes performance easier to review and improve, reducing the chance of costly impulsive moves.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vertex (VRTX) executive Joy Liu report?
Joy Liu reported selling 978 shares of Vertex Common Stock in an open-market transaction. The sale occurred on April 1, 2026, at an average price of $449.17 per share, according to the Form 4 insider trading report for Vertex Pharmaceuticals.
What role does Joy Liu hold at Vertex (VRTX)?
Joy Liu serves as Executive Vice President and Chief Legal Officer at Vertex Pharmaceuticals. Her position as a senior officer makes her transactions in Vertex stock reportable on Form 4 as an insider, providing transparency into her trading activity.
Does the Form 4 indicate any derivative transactions for Joy Liu at Vertex (VRTX)?
No derivative transactions are listed in this Form 4 for Joy Liu. The filing shows only a single non-derivative open-market sale of Common Stock and indicates no accompanying option exercises or other derivative activity in this specific report.
AI-generated analysis. How Rhea-AI works. Not financial advice.
